Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;18(6):888-90.
doi: 10.1093/neuonc/now085.

Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas

Affiliations

Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas

Dominique Figarella-Branger et al. Neuro Oncol. 2016 Jun.
No abstract available

Keywords: 1p/19q co-deletion; anaplastic oligodendrogliomas; microvascular proliferation; mitoses; necrosis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Results of univariate analysis for the 157 1p/19q co-deleted AO. (A). The 3 pathological subgroups (group 1 (>5 mitoses per 10-HPF but no MVP and no necrosis), group 2 (MVP and no necrosis) and group 3 (MVP and necrosis)) are predictive of OS (B) and PFS (C). Abbreviations: AO, anaplastic oligodendroglioma; MVP, microvascular proliferation; OS, overall survival; PFS, progression-free survival.

References

    1. Louis DN, Ohgaki H, Wiestler OD et al. . The 2007 WHO classification of tumours of the central nervous system . Acta Neuropathol. 2007;114(2):97–109. - PMC - PubMed
    1. Figarella-Branger D, Mokhtari K, Dehais C et al. . Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations. Neuro Oncol. 2014;16(9):1244–1254. - PMC - PubMed
    1. Louis DN, Perry A, Burger P et al. . International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 2014;24(5):429–435. - PMC - PubMed
    1. Giannini C, Burger PC, Berkey BA et al. . Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol. 2008;18(3):360–369. - PMC - PubMed
    1. van den Bent MJ, Carpentier AF, Brandes AA et al. . Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol. 2006;24(18):2715–2722. - PubMed

Publication types

Substances